We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+3.88%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$56.7B
AUM Growth
+$8.88B
(+19%)
Cap. Flow
+$7.92B
Cap. Flow
% of AUM
13.98%
Top 10 Holdings %
Top 10 Hldgs %
34.05%
Holding
2,107
New
102
Increased
1,467
Reduced
463
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$779M |
| 2 |
Apple
AAPL
|
+$539M |
| 3 |
Microsoft
MSFT
|
+$522M |
| 4 |
Meta Platforms (Facebook)
META
|
+$487M |
| 5 |
Tesla
TSLA
|
+$414M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$189M |
| 2 |
C.H. Robinson
CHRW
|
+$55.4M |
| 3 |
Fortinet
FTNT
|
+$55M |
| 4 |
AbbVie
ABBV
|
+$35.7M |
| 5 |
NextEra Energy
NEE
|
+$32.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.38% |
| 2 | Communication Services | 10.74% |
| 3 | Consumer Discretionary | 10.59% |
| 4 | Industrials | 8.58% |
| 5 | Consumer Staples | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
AtaiBeckley Inc
ATAI
$2.66B
| $65.6K | ﹤0.01% |
+16,042
| New | +$75.7K |
|
1927
SIGA Technologies
SIGA
$230M
| $65.1K | ﹤0.01% |
+10,659
| New | +$75.8K |
|
1928
Aclaris Therapeutics
ACRS
$772M
| $64.9K | ﹤0.01% |
21,553
+6,734
| +45% | +$17K |
|
1929
Organogenesis Holdings
ORGO
$301M
| $64.7K | ﹤0.01% |
12,483
+804
| +7% | +$3.9K |
|
1930
Custom Truck One Source
CTOS
$2.42B
| $63.4K | ﹤0.01% |
11,000
+692
| +7% | +$4.22K |
|
1931
ARKO Corp
ARKO
$851M
| $62.7K | ﹤0.01% |
13,809
+667
| +5% | +$2.99K |
|
|
EB
1932
DELISTED
Eventbrite
EB
| $61.5K | ﹤0.01% |
13,825
+892
| +7% | +$2.76K |
|
1933
B&G Foods
BGS
$290M
| $61.3K | ﹤0.01% |
14,259
+1,064
| +8% | +$4.75K |
|
|
SRTA
1934
Strata Critical Medical Inc
SRTA
$480M
| $60K | ﹤0.01% |
12,479
+1,368
| +12% | +$6.62K |
|
1935
Puma Biotechnology
PBYI
$391M
| $59.9K | ﹤0.01% |
+10,062
| New | +$53.4K |
|
1936
Acco Brands
ACCO
$399M
| $59.6K | ﹤0.01% |
15,972
+1,028
| +7% | +$3.81K |
|
|
RC
1937
Ready Capital
RC
$276M
| $59.1K | ﹤0.01% |
27,124
-4,068
| -13% | -$11.4K |
|
1938
Aura Biosciences
AURA
$728M
| $59K | ﹤0.01% |
+10,830
| New | +$64.3K |
|
1939
Candel Therapeutics
CADL
$738M
| $58.9K | ﹤0.01% |
+10,433
| New | +$56.1K |
|
1940
Atea Pharmaceuticals
AVIR
$369M
| $58.7K | ﹤0.01% |
16,440
+506
| +3% | +$1.61K |
|
1941
Holley
HLLY
$332M
| $57.7K | ﹤0.01% |
13,961
+3,777
| +37% | +$13.6K |
|
1942
Beyond Meat
BYND
$316M
| $57.5K | ﹤0.01% |
70,065
+57,472
| +456% | +$79.9K |
|
1943
Krispy Kreme
DNUT
$528M
| $56.4K | ﹤0.01% |
14,036
+845
| +6% | +$3.34K |
|
1944
Cadiz
CDZI
$260M
| $56.4K | ﹤0.01% |
+10,048
| New | +$53.9K |
|
1945
ADC Therapeutics
ADCT
$134M
| $55.5K | ﹤0.01% |
15,727
+3,339
| +27% | +$13.5K |
|
1946
Portillo's
PTLO
$329M
| $55.3K | ﹤0.01% |
12,188
+2,043
| +20% | +$10.7K |
|
1947
Orion
OEC
$385M
| $53.5K | ﹤0.01% |
+10,131
| New | +$55K |
|
1948
Blue Ridge Bankshares
BRBS
$323M
| $52.6K | ﹤0.01% |
12,326
+791
| +7% | +$3.43K |
|
1949
Allogene Therapeutics
ALLO
$635M
| $52.1K | ﹤0.01% |
38,034
+4,204
| +12% | +$5.54K |
|
|
SVC
1950
Service Properties Trust
SVC
$1.02B
| $52K | ﹤0.01% |
5,650
+363
| +7% | +$3.65K |
|
Similar funds
ProShare Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, ProShare Advisors held 2,107 positions worth $56.7B, up 19% from $47.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
ProShare Advisors deployed $7.92B of net new capital in Q4 2025, opening 102 new positions and adding to 1,467 existing holdings. Its largest new stake was CRH: 131,018 shares worth $16.4M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Broadcom, an estimated $189M trimmed.
- ProShare Advisors's largest Q4 2025 buy was CRH: 131,018 shares worth $16.4M.
- ProShare Advisors added most to NVIDIA in Q4 2025, an estimated $779M increase.
- ProShare Advisors's biggest Q4 2025 reduction was Broadcom, cutting an estimated $189M.
- ProShare Advisors fully exited Perrigo in Q4 2025, selling an estimated $27.6M.
- ProShare Advisors's ten largest holdings make up 34% of its $56.7B portfolio in Q4 2025.
- ProShare Advisors opened 102 new positions and closed 73 in Q4 2025.
- ProShare Advisors's portfolio value rose 19% quarter-over-quarter to $56.7B.
Based on ProShare Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.